[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368155-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368155-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-statistics-2025","Cancer statistics, 2025","","The American Cancer Society estimates the number of new cancer cases and cancer deaths in the United States each year and compiles recent, population-based incidence and outcome data. For 2025, the projected totals are 2,041,910 new cancer cases and 618,120 cancer deaths in the US. Cancer mortality continued to decline through 2022, preventing nearly 4.5 million deaths since 1991 due to reduced smoking, earlier detection for some cancers, and improved treatment. Persistent disparities remain, with the highest cancer mortality among Native American people and higher mortality among Black people for several cancers. Overall incidence trends differ by sex, with rising incidence in women and specific age- and sex-dependent patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-statistics-2025/368155/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-statistics-2025/368155.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are the 2025 projected numbers of new cancer cases and deaths in the United States?","Question",{"text":63,"@type":64},"In 2025, the American Cancer Society projects 2,041,910 new cancer cases and 618,120 cancer deaths in the United States.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How have cancer mortality and deaths changed over time according to the summary?",{"text":68,"@type":64},"Cancer mortality continued to decline through 2022, averting nearly 4.5 million deaths since 1991.",{"name":70,"@type":61,"acceptedAnswer":71},"Which data sources are used for population-based cancer incidence and survival statistics?",{"text":72,"@type":64},"Incidence data come from the SEER program (since 1973) and CDC NPCR (since 1995). Survival statistics are based on SEER 8 areas plus additional registries, with follow-up through 2021.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368155,1790301189,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","DOI: 10. 3322/caac.21871  \nARTICLE  \nCancer statistics, 2025  \nRebecca L. Siegel MPH1  | Tyler B. Kratzer MPH1  | Angela N. Giaquinto MSPH1  | Hyuna Sung PhD 1  | Ahmedin Jemal DVM, PhD2  \n1Cancer Surveillance Research, American Cancer Society, Atlanta, Georgia, USA 2Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA  \nCorrespondence  \nRebecca L. Siegel, Cancer Surveillance Research, American Cancer Society, 270 Peachtree Street NW, Suite 1300, Atlanta, GA 30303, USA.  \nEmail: [rebecca.siegel@cancer.org](rebecca.siegel@cancer.org)  \nABSTRACT  \nEach year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐ based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collected by the National Center for Health Statistics (through 2022). In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2022, averting nearly 4.5 million deaths since 1991 because of smoking reductions, earlier detection for some cancers, and improved treatment. Yet alarming disparities persist; Native American people bear the highest cancer mortality, including rates that are two to three times those in White people for kidney, liver, stomach, and cervical cancers. Similarly, Black people have two‐fold higher mortality than White people for prostate, stomach, and uterine corpus cancers. Overall cancer incidence has generally declined in men but has risen in women, narrowing the male‐to‐female rate ratio (RR) from a peak of 1.6 (95% confidence interval, 1.57–1. 61) in 1992 to 1.1 (95% confidence interval, 1.12–1. 12) in 2021. However, rates in women aged 50–64 years have already surpassed those in men (832.5 vs. 830.6 per 100,000), and younger women (younger than 50 years) have an 82% higher incidence rate than their male counterparts (141.1 vs. 77.4 per 100,000), up from 51% in 2002. Notably, lung cancer incidence in women surpassed that in men among people younger than 65 years in 2021 (15.7 vs. 15.4 per 100,000; RR, 0. 98, p = 0.03). In summary, cancer mortality continues to decline, but future gains are threatened by rampant racial inequalities and a growing burden of disease in middle‐aged and young adults, especially women. Continued progress will require investment in cancer prevention and access to equitable treatment, especially for Native American and Black individuals.  \nKEYWORDS  \ncancer cases, cancer statistics, death rates, incidence, mortality  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2025 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nINTRODUCTION  \nCancer is the second leading cause of death in the United States overall and the leading cause among people younger than 85 years. The coronavirus disease 2019 (COVID‐19) pandemic caused delaysin the diagnosis and treatment of cancer in 2020 because of healthcare setting closures, loss of employment and health insurance, and fear of COVID‐19 exposure. 1,2 The extent to which these delays lead to increased diagnosis of advanced‐stage disease and higher cancer mortality will be revealed gradually over many years. A recent modeling study estimated 4000 to 7000 excess deaths from colorectal cancer (CRC) by 2040, depending on the speed of screening recovery.3 What is already established is the disproportionate direct and indirect impact of the pandemic on communities of color,4,5 including slower recovery of cancer screening,6 which will likely exacerbate existing cancer dispari","cbCaikLwCcZriwaE","https://ap.wps.com/l/cbCaikLwCcZriwaE","pdf",4002831,36,"English","# Introduction\n# Materials and Methods\n## Data sources","[{\"question\":\"What are the 2025 projected numbers of new cancer cases and deaths in the United States?\",\"answer\":\"In 2025, the American Cancer Society projects 2,041,910 new cancer cases and 618,120 cancer deaths in the United States.\"},{\"question\":\"How have cancer mortality and deaths changed over time according to the summary?\",\"answer\":\"Cancer mortality continued to decline through 2022, averting nearly 4.5 million deaths since 1991.\"},{\"question\":\"Which data sources are used for population-based cancer incidence and survival statistics?\",\"answer\":\"Incidence data come from the SEER program (since 1973) and CDC NPCR (since 1995). Survival statistics are based on SEER 8 areas plus additional registries, with follow-up through 2021.\"}]","Cancer statistics, 2025 | PDF",1790175312,91,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9c35fa6d6fc04201437e3d3b0549629.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f50788c7000d6974f2e7c5f55aae69d1.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c68cbd33a36f7799a048da6a5c29016.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e757703a1f411adc264306e5e83020a.webp",980,1287]